Previous ischemia and reperfusion injury results in resistance of the kidney against subsequent ischemia and reperfusion insult in mice; A role for the Akt signal pathway

Nephrology Dialysis Transplantation

Volumn 27, Issue 10, 2012, Pages 3762-3770

  Jang, Hee Seong ^a   Kim, Jinu ^a   Kim, Ki Young ^a   Kim, Jee In ^a   Cho, Min Hyun ^a   Park, Kwon Moo ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

acute kidney injury; Akt; apoptosis; ischemia and reperfusion; ischemic pre conditioning

Indexed keywords

CREATININE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; WORTMANNIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE PREDISPOSITION; DISEASE RESISTANCE; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; INTRACELLULAR SIGNALING; ISCHEMIC PRECONDITIONING; KIDNEY ISCHEMIA; KIDNEY TUBULE CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPERFUSION INJURY;

ANDROSTADIENES; ANIMALS; APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; BCL-X PROTEIN; ISCHEMIA; ISCHEMIC PRECONDITIONING; KIDNEY; KIDNEY TUBULES; MALE; MICE; MICE, INBRED BALB C; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

EID: 84868580063     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs097     Document Type: Article

References (47)

1. Pong K. Ischaemic preconditioning: therapeutic implications for stroke?. Expert Opin Ther Targets 2004; 8: 125-139
2. Bonventre JV. Kidney ischemic preconditioning. Curr Opin Nephrol Hypertens 2002; 11: 43-48
3. Nandagopal K, Dawson TM, Dawson VL. Critical role for nitric oxide signaling in cardiac and neuronal ischemic preconditioning and tolerance. J Pharmacol Exp Ther 2001; 297: 474-478
4. Ambros JT, Herrero-Fresneda I, Borau OG et al. Ischemic preconditioning in solid organ transplantation: from experimental to clinics. Transpl Int 2007; 20: 219-229
5. Park KM, Chen A, Bonventre JV. Prevention of kidney ischemia/reperfusion- induced functional injury and JNK, p.38, and MAPK kinase activation by remote ischemic pretreatment. J Biol Chem 2001; 276: 11870-11876
6. Park KM, Byun JY, Kramers C et al. Inducible nitric-oxide synthase is an important contributor to prolonged protective effects of ischemic preconditioning in the mouse kidney. J Biol Chem 2003; 278: 27256-27266
7. Burgering BM, Coffer PJ. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 1995; 376: 599-602
8. Shiojima I, Walsh K. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ Res 2002; 90: 1243-1250
9. Franke TF, Kaplan DR, Cantley LC. PI3K: downstream AKTion blocks apoptosis. Cell 1997; 88: 435-437
10. Franke TF, Yang SI, Chan TO et al. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 1995; 81: 727-736
11. Brunet A, Bonni A, Zigmond MJ et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999; 96: 857-868
12. Datta SR, Dudek H, Tao X et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997; 91: 231-241
13. Downward J. How BAD phosphorylation is good for survival. Nat Cell Biol 1999; 1: E33-E35
14. Shimizu S, Narita M, Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 1999; 399: 483-487
15. Kharbanda S, Pandey P, Schofield L et al. Role for Bcl-xL as an inhibitor of cytosolic cytochrome C accumulation in DNA damageinduced apoptosis. Proc Natl Acad Sci USA 1997; 94: 6939-6942
16. Andreucci M, Michael A, Kramers C et al. Renal ischemia/reperfusion and ATP depletion/repletion in LLC-PK(1) cells result in phosphorylation of FKHR and FKHRL1. Kidney Int 2003; 64: 1189-1198
17. Ban K, Cooper AJ, Samuel S et al. Phosphatidylinositol 3-kinase gamma is a critical mediator of myocardial ischemic and adenosinemediated preconditioning. Circ Res 2008; 103: 643-653
18. Molnarfi N, Brandt KJ, Gruaz L et al. Differential regulation of cytokine production by PI3Kdelta in human monocytes upon acute and chronic inflammatory conditions. Mol Immunol 2008; 45: 3419-3427
19. Buchi ER. Cell death in the rat retina after a pressure-induced ischaemia-reperfusion insult: an electron microscopic study. I. Ganglion cell layer and inner nuclear layer. Exp Eye Res 1992; 55: 605-613
20. Rehni AK, Singh N. Role of phosphoinositide 3-kinase in ischemic postconditioning-induced attenuation of cerebral ischemia-evoked behavioral deficits in mice. Pharmacol Rep 2007; 59: 192-198
21. Ohta T, Ohmichi M, Hayasaka T et al. Inhibition of phosphatidylinositol 3-kinase increases efficacy of cisplatin in in vivo ovarian cancer models. Endocrinology 2006; 147: 1761-1769
22. Wipf P, Minion DJ, Halter RJ et al. Synthesis and biological evaluation of synthetic viridins derived from C(20)-heteroalkylation of the steroidal PI-3-kinase inhibitor wortmannin. Org Biomol Chem 2004; 2: 1911-1920
23. Jang HS, Kim J, Park YK et al. Infiltrated macrophages contribute to recovery after ischemic injury but not to ischemic preconditioning in kidneys. Transplantation 2008; 85: 447-455
24. Kim J, Jang HS, Park KM. Reactive oxygen species generated by renal ischemia and reperfusion trigger protection against subsequent renal ischemia and reperfusion injury in mice. Am J Physiol Renal Physiol 2010; 298: F158-F166
25. Kim J, Jung KJ, Park KM. Reactive oxygen species differently regulate renal tubular epithelial and interstitial cell proliferation after ischemia and reperfusion injury. Am J Physiol Renal Physiol 2010; 298: F1118-F1129
26. Park KM, Cho HJ, Bonventre JV. Orchiectomy reduces susceptibility to renal ischemic injury: a role for heat shock proteins. Biochem Biophys Res Commun 2005; 328: 312-317
27. Halliwell B, Gutteridge JM, Aruoma OI. The deoxyribose method: a simple "test-tube" assay for determination of rate constants for reactions of hydroxyl radicals. Anal Biochem 1987; 165: 215-219
28. Castaneda MP, Swiatecka-Urban A, Mitsnefes MM et al. Activation of mitochondrial apoptotic pathways in human renal allografts after ischemiareperfusion injury. Transplantation 2003; 76: 50-54
29. Ueda N, Shah SV. Tubular cell damage in acute renal failure-apoptosis, necrosis, or both. Nephrol Dial Transplant 2000; 15: 318-323
30. Ueda N, Kaushal GP, Shah SV. Apoptotic mechanisms in acute renal failure. Am J Med 2000; 108: 403-415
31. Bonegio R, Lieberthal W. Role of apoptosis in the pathogenesis of acute renal failure. Curr Opin Nephrol Hypertens 2002; 11: 301-308
32. Kim J, Kim KY, Jang HS et al. Role of cytosolic NADP +-dependent isocitrate dehydrogenase in ischemia-reperfusion injury in mouse kidney. Am J Physiol Renal Physiol 2009; 296: F622-F633
33. Park KM, Kim JI, Ahn Y et al. Testosterone is responsible for enhanced susceptibility of males to ischemic renal injury. J Biol Chem 2004; 279: 52282-52292
34. Chien CT, Shyue SK, Lai MK. Bcl-xL augmentation potentially reduces ischemia/reperfusion induced proximal and distal tubular apoptosis and autophagy. Transplantation 2007; 84: 1183-1190
35. Gobe G, Zhang XJ, Cuttle L et al. Bcl-2 genes and growth factors in the pathology of ischaemic acute renal failure. Immunol Cell Biol 1999; 77: 279-286
36. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74: 609-619
37. Belkhiri A, Dar AA, Zaika A et al. t-Darpp promotes cancer cell survival by up-regulation of Bcl2 through Akt-dependent mechanism. Cancer Res 2008; 68: 395-403
38. Huang J, Ito Y, Morikawa M et al. Bcl-xL gene transfer protects the heart against ischemia/reperfusion injury. Biochem Biophys Res Commun 2003; 311: 64-70
39. Honda K, Tohyama T, Kotegawa H et al. Protective effect of adenomediated human Bcl-xL gene transfer to the mouse liver in a partial ischemia/reperfusion model. J Surg Res 2009; 157: e107-e116
40. Gobe G, Zhang XJ, Willgoss DA et al. Relationship between expression of Bcl-2 genes and growth factors in ischemic acute renal failure in the rat. J Am Soc Nephrol 2000; 11: 454-467
41. Armstrong SC. Protein kinase activation and myocardial ischemia/reperfusion injury. Cardiovasc Res 2004; 61: 427-436
42. Matsui T, Tao J, del Monte F et al. Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 2001; 104: 330-335
43. Daemen MA, van 't Veer C, Denecker G et al. Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest 1999; 104: 541-549
44. Lee HT, Gallos G, Nasr SH et al. A1 adenosine receptor activation inhibits inflammation, necrosis, and apoptosis after renal ischemiareperfusion injury in mice. J Am Soc Nephrol 2004; 15: 102-111
45. Linares-Palomino J, Husainy MA, Lai VK et al. Selective blockade of protein kinase B protects the rat and human myocardium against ischaemic injury. J Physiol 2010; 588: 2173-2191
46. Huang Y, Cen LP, Luo JM et al. Differential roles of phosphatidylinositol 3-kinase/akt pathway in retinal ganglion cell survival in rats with or without acute ocular hypertension. Neuroscience 2008; 153: 214-225
47. Dreixler JC, Hemmert JW, Shenoy SK et al. The role of Akt/protein kinase B subtypes in retinal ischemic preconditioning. Exp Eye Res 2009; 88: 512-521